Experimental study on the treatment of norepinephrine transporter-overexpressing pheochromocytomas and paragangliomas: a synthetic lethality strategy combining 131I-MIBG with PARP inhibitors. The gene discussed is SLC6A2; the disease is hereditary pheochromocytoma-paraganglioma.